Advancing cooperation on health technology assessment (HTA) and supporting the implementation of the new EU legal framework on HTA
Deliverable D7.1 Guidance for the interaction between HTD and HTA is now published.
EUnetHTA 21 is pleased to announce the publication of the deliverable D7.1. This EUnetHTA 21 deliverable focusses on the guidance for the interaction between HTA bodies
Deliverable D4.4 on Endpoints is now published.
EUnetHTA 21 is pleased to announce the publication of the deliverable D4.4 on Endpoints. The objective of this deliverable was to develop a practical guideline on how to
EUnetHTA 21 announces publication of five deliverables
EUnetHTA 21 is pleased to announce the publication of five deliverables: D4.3.1 Practical guideline for direct and indirect comparisons, D4.5 Practical guideline on applicability of
[New] Patient input and healthcare professional input requested for second medical device Joint Clinical Assessment.
EUnetHTA 21 is pleased to announce it has started a second Joint Clinical Assessment on a medical device. The technology under assessment is a device
Patient input and healthcare professional input requested for first medical device Joint Clinical Assessment
EUnetHTA 21 is pleased to announce it has started a Joint Clinical Assessment on a medical device for male patients with urinary symptoms associated with
EUnetHTA 21-EMA Bilateral Meeting Minutes available now.
We are pleased to announce the publication of the EUnetHTA 21 – EMA bilateral meeting minutes. The joint meeting was held in June 2022. It
Joint HTA Work
EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Scientific Consultations, Parallel Consultations, and Post Launch Evidence Generation (PLEG). Find out more here.
Tools
EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.
COVID-19 Response
EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.
Get Involved
EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.
